Tango Therapeutics, Inc. (TNGX)
$24.51+2.64%Close
SELLCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $3.0B
- Avg volume
- 3.6M
- Beta
- 1.15
- P/E (TTM)
- -28.84
- Short % float
- 54.39%
- Days to cover
- 19.1
- SI change
- +4.4%
- 1W
- -3.08%
- 1M
- -7.96%
- 3M
- +21.10%
- YTD
- +174.47%
- vs SPY 1W
- -1.89%
- vs SPY 1M
- -11.28%
- vs SPY 3M
- +18.71%
- vs SPY YTD
- +162.71%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CTMXBUYCytomX Therapeutics, Inc.RECOVERYQ 8$3.29+0.30%
- LCTXSELLLineage Cell Therapeutics, Inc.RECOVERYQ 11$1.09+0.93%
- STOKBUYStoke Therapeutics, Inc.RECOVERYQ 13$32.32+0.09%
- TNDMBUYTandem Diabetes Care, Inc.RECOVERYQ -7$22.22-0.45%
- SCLXSELLScilex Holding CompanyCRISISQ -22$5.66-1.22%
- BRTXSELLBioRestorative Therapies, Inc.CRISISQ -14$0.21-4.55%
- ISPCSELLiSpecimen Inc.CRISISQ -26$1.57-7.10%
- SGHTBUYSight Sciences, Inc.RECOVERYQ -13$8.38+1.45%
- AEMDSELLAethlon Medical, Inc.CRISISQ -9$2.64-3.30%
- AMRNBUYAmarin Corporation plcRECOVERYQ 2$13.84-1.77%
- MSPRSELLMSP Recovery, Inc.RECOVERYQ -29$0.00
- DNTHBUYDianthus Therapeutics, Inc.BULLQ 4$110.07-0.93%
Industry peers
FMP comparable companies · ranked by market cap
- NRIXBUYNurix Therapeutics, Inc.$2.8BBULLQ 13$26.72-1.68%
- KODSELLKodiak Sciences Inc.$2.4BCRISISQ 37$38.33-2.90%
- URGNBUYUroGen Pharma Ltd.$2.3BBULLQ 23$46.86-1.49%
- XNCRBUYXencor, Inc.$2.1BBULLQ 17$27.80+4.32%
- SEPNBUYSepterna Inc$1.8BCRISISQ 29$40.00+1.30%
- FTRESELLFortrea Holdings Inc.$1.7BBEARQ -4$18.39-0.44%
- BCAXSELLBicara Therapeutics Inc. Common Stock$1.6BCRISISQ 0$23.90-1.34%
- KURABUYKura Oncology, Inc.$1.1BRECOVERYQ 13$11.89+4.29%
- PROKSELLProKidney Corp.$541MRECOVERYQ 0$1.61+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 6
- GROWTH
- 19
- GARP
- 7
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-15.4%
REV YoY-
ROE-25.7%
EPS YoY-
ROA-11.5%
GROSS98
OP-253
NET-230
[VALUATION]
P/E TTM-28.84
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B3.59
P/FCF-
EV/EBITDA-30.07
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.12
ALTMAN Z-
CURR RATIO50.82
ND/EBITDA-
BETA1.15
